Earnings Feed
Start Free
Home/Insiders/GREENACRE MARTYN D
GM
SEC Insider//CIK 0001209727

GREENACRE MARTYN D

CIK 00012097276 companiesCAMBRIDGE, MA
SEC Profile

Transactions

50

Companies

6

Filings

13

CIK

0001209727

Recent Transactions

50 trades
  • Award
    CURIS INC$CRIS

    Non Qualified Stock Option

    2025-05-20$3.13/sh+14,400→ 14,400 total
  • Award
    CURIS INC$CRIS

    Non Qualified Stock Option

    2025-01-28$3.13/sh+1,600→ 1,600 total
  • Award
    CURIS INC$CRIS

    Non Qualified Stock Option

    2024-05-21$11.62/sh+4,250→ 4,250 total
  • Award
    CURIS INC$CRIS

    Non Qualified Stock Option

    2023-01-23+85,000→ 85,000 total
  • Award
    CURIS INC$CRIS

    Non Qualified Stock Option

    2022-01-31+85,000→ 85,000 total
  • Award
    CURIS INC$CRIS

    Non Qualified Stock Option

    2021-01-28+33,000→ 33,000 total
  • Award
    CURIS INC$CRIS

    Non Qualified Stock Option

    2020-03-02+180,000→ 180,000 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2019-01-23$1.05/sh−18,500→ 26,089 total
  • Award
    CURIS INC$CRIS

    Non Qualified Stock Option

    2019-01-21+180,000→ 180,000 total
  • Award
    CURIS INC$CRIS

    Common stock

    2018-01-22+185,000→ 222,945 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Common Stock

    2017-05-31$1.39/sh+10,000→ 45,138 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Non-qualified stock option (right to buy)

    2017-05-31−10,000→ 0 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Non-qualified stock option (right to buy)

    2017-05-31−5,000→ 0 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Common Stock

    2017-05-31$1.39/sh+5,000→ 50,138 total
  • Tax Payment
    CURIS INC$CRIS

    Common Stock

    2017-05-31$1.71/sh−12,193→ 37,945 total
  • Award
    CURIS INC$CRIS

    Non-qualified stock option

    2017-02-28+120,000→ 120,000 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2016-05-27$1.69/sh−5,000→ 35,183 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Non-qualified stock option (right to buy)

    2016-05-27$1.67/sh−5,000→ 0 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Common Stock

    2016-05-27$1.67/sh+5,000→ 40,183 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2016-05-27$1.69/sh−10,000→ 35,183 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Common Stock

    2016-05-27$1.67/sh+10,000→ 45,183 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Non-qualified stock option (right to buy)

    2016-05-27$1.67/sh−10,000→ 0 total
  • Award
    CURIS INC$CRIS

    Non-qualified stock option

    2016-01-19+50,000→ 50,000 total
  • Award
    LISATA THERAPEUTICS, INC.$LSTA

    Common stock, par value $0.001 per share

    2015-06-02+10,000→ 88,531 total
  • Award
    CURIS INC$CRIS

    Non-qualified stock option (right to buy)

    2015-01-26+25,000→ 25,000 total
  • Award
    LISATA THERAPEUTICS, INC.$LSTA

    Common stock, par value $0.001 per share

    2015-01-02+14,000→ 78,531 total
  • Award
    CURIS INC$CRIS

    Non-qualified stock option (right to buy)

    2014-01-27+25,000→ 25,000 total
  • Award
    LISATA THERAPEUTICS, INC.$LSTA

    Common stock, par value $0.001 per share

    2014-01-02+14,000→ 64,531 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Common stock

    2013-05-02$1.09/sh+60,000→ 95,138 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Non-qualified stock option (right to buy)

    2013-05-02$2.43/sh−60,000→ 0 total
  • Sale
    CURIS INC$CRIS

    Common stock

    2013-05-02$3.67/sh−60,000→ 35,138 total
  • Award
    CURIS INC$CRIS

    Non-qualified stock option (right to buy)

    2013-01-17+25,000→ 25,000 total
  • Award
    LISATA THERAPEUTICS, INC.$LSTA

    Common stock, par value $0.001 per share

    2013-01-04+120,000→ 505,306 total
  • Sale
    CURIS INC$CRIS

    Common stock

    2012-09-19$4.31/sh−50,000→ 35,138 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Non-qualified stock option (right to buy)

    2012-09-19$1.09/sh−50,000→ 0 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Common stock

    2012-09-19$1.09/sh+50,000→ 85,138 total
  • Award
    LISATA THERAPEUTICS, INC.$LSTA

    Common stock, par value $0.001 per share

    2012-06-29+15,306→ 385,306 total
  • Purchase
    LISATA THERAPEUTICS, INC.$LSTA

    Common stock, $0.001 par value

    2012-05-11+250,000→ 370,000 total
  • Purchase
    LISATA THERAPEUTICS, INC.$LSTA

    Warrant (Right to Buy)

    2012-05-11+250,000→ 250,000 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Common stock

    2012-03-28$1.09/sh+5,000→ 115,138 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Non-qualified stock option (right to buy)

    2012-03-28$1.50/sh−75,000→ 0 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Non-qualified stock option (right to buy)

    2012-03-28$1.09/sh−5,000→ 0 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Common stock

    2012-03-28$1.50/sh+75,000→ 110,138 total
  • Sale
    CURIS INC$CRIS

    Common stock

    2012-03-28$4.92/sh−80,000→ 35,138 total
  • Award
    CURIS INC$CRIS

    Non-qualified stock option (right to buy)

    2012-01-05+50,000→ 25,000 total
  • Award
    LISATA THERAPEUTICS, INC.$LSTA

    Common Stock, $0.001 par value per share

    2012-01-04+120,000→ 120,000 total
  • Disposition to Issuer
    CEPHALON INC

    Non-Qualified Stock Option

    2011-10-14−10,000→ 0 total
  • Disposition to Issuer
    CEPHALON INC

    Non-Qualified Stock Option

    2011-10-14−15,000→ 0 total
  • Disposition to Issuer
    CEPHALON INC

    Non-Qualified Stock Option

    2011-10-14−10,000→ 0 total
  • Disposition to Issuer
    CEPHALON INC

    Non-Qualified Stock Option

    2011-10-14−10,000→ 0 total

Companies

6

Recent Filings

13

Address

45 MOULTON STREET

CAMBRIDGE, MA, 02138

View on SEC.gov